The venture arm of GlaxoSmithKline joined investors in ZappRx, a prescription app, in a second instance recently of big pharma putting cash into a mobile health firm.
ZappRx announced it had closed a $1 million round from backers led by current investor Atlas Venture but also including GSK-backed SR One.
The round follows $1 million invested by Atlas Venture in September 2013.